Last 12 months
Inside the activity.
1 purchase rows · 24 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 2 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 7 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 06, 2020 Filed May 8, 2020 21:23 UTC |
Payson NormanDirector
|
SaleCommon Stock | 5,260 | $22.01 | $115,772.60 |
DisclosureSEC source: 0001179110-20-005633 · edgar.xml · nonDerivative · entry 1 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 744,939 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.42 to $22.41 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (7) and (8). F3 · ownership.nature: The reportable securities are directly held by Melinda B. Payson and Robert L. Carson, Trustee of The Melinda B. Payson 2018 Grantor Retained Annuity Trust dated November 28, 2018 ("MBP GRAT"). The Reporting Person's spouse is a trustee of the MBP GRAT. Read SEC document |
| May 05, 2020 Filed May 7, 2020 16:26 UTC |
BONDERMAN DAVID10% owner
COULTER JAMES G10% owner
|
SaleCommon Stock | 3,300 | $21.75 | $71,775.00 |
DisclosureSEC source: 0001387131-20-004536 · ownership.xml · nonDerivative · entry 2 TPG Group Holdings (SBS) Advisors, Inc. · CIK 0001495741 · 10% owner BONDERMAN DAVID · CIK 0000860866 · 10% owner COULTER JAMES G · CIK 0001099776 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Explanation of Responses Disclosed balance after: 20,028,758 F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by TPG Biotech III. F1 · ownership.nature: David Bonderman and James G. Coulter are the sole shareholders of TPG Group Holdings (SBS) Advisors, Inc. (together with Messrs. Bonderman and Coulter, the "Reporting Persons"), which is the sole member of TPG Group Holdings (SBS) Advisors, LLC, which is the general partner of TPG Group Holdings (SBS), L.P., which is the sole member of TPG Holdings I-A, LLC, which is the general partner of TPG Holdings I, L.P., which is the sole member of TPG Biotechnologies GenPar III Advisors, LLC, which is the general partner of TPG Biotechnology GenPar III, L.P., which is the general partner of TPG Biotechnology Partners III, L.P. ("TPG Biotech III"), which directly holds 19,992,091 shares of Common Stock, $0.0001 par value per share ("Common Stock"), of Progyny, Inc. (the "Issuer"). F6 · ownership.nature: Because of the relationship between the Reporting Persons and TPG Biotech III, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of the greater of their respective direct or indirect pecuniary interests in the profits or capital accounts of TPG Biotech III. Each of TPG Biotech III and each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of TPG Biotech III's or such Reporting Person's pecuniary interest therein, if any. F7 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| May 05, 2020 Filed May 7, 2020 16:26 UTC |
BONDERMAN DAVID10% owner
COULTER JAMES G10% owner
|
SaleCommon Stock | 64,004 | $22.75 | $1,455,796.58 |
DisclosureSEC source: 0001387131-20-004536 · ownership.xml · nonDerivative · entry 1 TPG Group Holdings (SBS) Advisors, Inc. · CIK 0001495741 · 10% owner BONDERMAN DAVID · CIK 0000860866 · 10% owner COULTER JAMES G · CIK 0001099776 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Explanation of Responses Disclosed balance after: 20,032,058 F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by TPG Biotech III. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.07 to $23.06, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "Commission"), upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · ownership.nature: David Bonderman and James G. Coulter are the sole shareholders of TPG Group Holdings (SBS) Advisors, Inc. (together with Messrs. Bonderman and Coulter, the "Reporting Persons"), which is the sole member of TPG Group Holdings (SBS) Advisors, LLC, which is the general partner of TPG Group Holdings (SBS), L.P., which is the sole member of TPG Holdings I-A, LLC, which is the general partner of TPG Holdings I, L.P., which is the sole member of TPG Biotechnologies GenPar III Advisors, LLC, which is the general partner of TPG Biotechnology GenPar III, L.P., which is the general partner of TPG Biotechnology Partners III, L.P. ("TPG Biotech III"), which directly holds 19,992,091 shares of Common Stock, $0.0001 par value per share ("Common Stock"), of Progyny, Inc. (the "Issuer"). F6 · ownership.nature: Because of the relationship between the Reporting Persons and TPG Biotech III, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of the greater of their respective direct or indirect pecuniary interests in the profits or capital accounts of TPG Biotech III. Each of TPG Biotech III and each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of TPG Biotech III's or such Reporting Person's pecuniary interest therein, if any. F7 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests. Read SEC document |
| May 04, 2020 Filed May 5, 2020 19:19 UTC |
Bealer JenniferEVP, General Counsel
|
GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-005503 · edgar.xml · nonDerivative · entry 4 Bealer Jennifer · CIK 0001789513 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,933 F1 · shares: Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). This was an one-time merit grant made pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. One-fourth (1/4th) of the RSUs vest on October 25, 2020, and the remaining RSUs vest in equal quarterly installments thereafter through October 25, 2023, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| May 01, 2020 Filed May 5, 2020 19:19 UTC |
Bealer JenniferEVP, General Counsel
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 8,222 | $0.00 Strike: $3.96 | $0.00 |
DisclosureSEC source: 0001179110-20-005503 · edgar.xml · derivative · entry 6 Bealer Jennifer · CIK 0001789513 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,138 Underlying: Common Stock · 8,222 shares Expires 2029-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on March 20, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| May 01, 2020 Filed May 5, 2020 19:19 UTC |
Bealer JenniferEVP, General Counsel
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 13,750 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-20-005503 · edgar.xml · derivative · entry 5 Bealer Jennifer · CIK 0001789513 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,251 Underlying: Common Stock · 13,750 shares Expires 2027-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on October 30, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. F3 · balance_after: This number reports the corrected number of shares subject to the Option after the partial exercises of the Option on October 24, 2019, October 30, 2019 and May 1, 2020. Read SEC document |
| May 01, 2020 Filed May 5, 2020 19:19 UTC |
Bealer JenniferEVP, General Counsel
|
Tax withholdingCommon Stock | 3,778 | $21.69 | $81,944.82 |
DisclosureSEC source: 0001179110-20-005503 · edgar.xml · nonDerivative · entry 3 Bealer Jennifer · CIK 0001789513 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,933 Read SEC document |
| May 01, 2020 Filed May 5, 2020 19:19 UTC |
Bealer JenniferEVP, General Counsel
|
Exercise / conversionCommon Stock | 8,222 | $3.96 | $32,559.12 |
DisclosureSEC source: 0001179110-20-005503 · edgar.xml · nonDerivative · entry 2 Bealer Jennifer · CIK 0001789513 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,711 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2020 Filed May 5, 2020 19:19 UTC |
Bealer JenniferEVP, General Counsel
|
Exercise / conversionCommon Stock | 13,750 | $0.91 | $12,512.50 |
DisclosureSEC source: 0001179110-20-005503 · edgar.xml · nonDerivative · entry 1 Bealer Jennifer · CIK 0001789513 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,489 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 30, 2020 Filed May 1, 2020 20:25 UTC |
Payson NormanDirector
|
SaleCommon Stock | 4,500 | $23.42 | $105,390.00 |
DisclosureSEC source: 0001179110-20-005358 · edgar.xml · nonDerivative · entry 9 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 832,000 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.08 to $23.835 inclusive. F6 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust ("NMP Trust"). Read SEC document |
| April 30, 2020 Filed May 1, 2020 20:25 UTC |
Payson NormanDirector
|
SaleCommon Stock | 6,250 | $23.42 | $146,375.00 |
DisclosureSEC source: 0001179110-20-005358 · edgar.xml · nonDerivative · entry 8 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 750,199 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.08 to $23.835 inclusive. F5 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Robert L. Carson, Trustee of The Norman C. Payson 2018 Grantor Retained Annuity Trust dated November 28, 2018 ("NCP GRAT"). The Reporting Person is a trustee of the NCP GRAT. Read SEC document |
| April 30, 2020 Filed May 1, 2020 20:25 UTC |
Payson NormanDirector
|
SaleCommon Stock | 6,250 | $23.42 | $146,375.00 |
DisclosureSEC source: 0001179110-20-005358 · edgar.xml · nonDerivative · entry 7 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 750,199 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.08 to $23.835 inclusive. F3 · ownership.nature: The reportable securities are directly held by Melinda B. Payson and Robert L. Carson, Trustee of The Melinda B. Payson 2018 Grantor Retained Annuity Trust dated November 28, 2018 ("MBP GRAT"). The Reporting Person's spouse is a trustee of the MBP GRAT. Read SEC document |
| April 29, 2020 Filed May 1, 2020 20:25 UTC |
Payson NormanDirector
|
SaleCommon Stock | 1,372 | $23.81 | $32,667.32 |
DisclosureSEC source: 0001179110-20-005358 · edgar.xml · nonDerivative · entry 6 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 836,500 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.51 to $24.01 inclusive. F6 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust ("NMP Trust"). Read SEC document |
| April 29, 2020 Filed May 1, 2020 20:25 UTC |
Payson NormanDirector
|
SaleCommon Stock | 3,128 | $22.94 | $71,756.32 |
DisclosureSEC source: 0001179110-20-005358 · edgar.xml · nonDerivative · entry 5 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 837,872 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.51 to $23.495 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4) and (7). F6 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust ("NMP Trust"). Read SEC document |
| April 29, 2020 Filed May 1, 2020 20:25 UTC |
Payson NormanDirector
|
SaleCommon Stock | 1,906 | $23.81 | $45,381.86 |
DisclosureSEC source: 0001179110-20-005358 · edgar.xml · nonDerivative · entry 4 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 756,449 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.51 to $24.01 inclusive. F5 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Robert L. Carson, Trustee of The Norman C. Payson 2018 Grantor Retained Annuity Trust dated November 28, 2018 ("NCP GRAT"). The Reporting Person is a trustee of the NCP GRAT. Read SEC document |
| April 29, 2020 Filed May 1, 2020 20:25 UTC |
Payson NormanDirector
|
SaleCommon Stock | 4,344 | $22.94 | $99,651.36 |
DisclosureSEC source: 0001179110-20-005358 · edgar.xml · nonDerivative · entry 3 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 758,355 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.51 to $23.495 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4) and (7). F5 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Robert L. Carson, Trustee of The Norman C. Payson 2018 Grantor Retained Annuity Trust dated November 28, 2018 ("NCP GRAT"). The Reporting Person is a trustee of the NCP GRAT. Read SEC document |
| April 29, 2020 Filed May 1, 2020 20:25 UTC |
Payson NormanDirector
|
SaleCommon Stock | 1,906 | $23.81 | $45,381.86 |
DisclosureSEC source: 0001179110-20-005358 · edgar.xml · nonDerivative · entry 2 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 756,449 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.51 to $24.01 inclusive. F3 · ownership.nature: The reportable securities are directly held by Melinda B. Payson and Robert L. Carson, Trustee of The Melinda B. Payson 2018 Grantor Retained Annuity Trust dated November 28, 2018 ("MBP GRAT"). The Reporting Person's spouse is a trustee of the MBP GRAT. Read SEC document |
| April 29, 2020 Filed May 1, 2020 20:25 UTC |
Payson NormanDirector
|
SaleCommon Stock | 4,344 | $22.94 | $99,651.36 |
DisclosureSEC source: 0001179110-20-005358 · edgar.xml · nonDerivative · entry 1 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 758,355 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.51 to $23.495 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4) and (7). F3 · ownership.nature: The reportable securities are directly held by Melinda B. Payson and Robert L. Carson, Trustee of The Melinda B. Payson 2018 Grantor Retained Annuity Trust dated November 28, 2018 ("MBP GRAT"). The Reporting Person's spouse is a trustee of the MBP GRAT. Read SEC document |
| April 23, 2020 Filed Apr 25, 2020 01:37 UTC |
Payson NormanDirector
|
SaleCommon Stock | 449 | $23.37 | $10,493.13 |
DisclosureSEC source: 0001209191-20-025740 · doc4.xml · nonDerivative · entry 21 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 841,000 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.19 to $23.49 inclusive. F9 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of the NMP Trust. Read SEC document |
| April 23, 2020 Filed Apr 25, 2020 01:37 UTC |
Payson NormanDirector
|
SaleCommon Stock | 3,314 | $22.79 | $75,526.06 |
DisclosureSEC source: 0001209191-20-025740 · doc4.xml · nonDerivative · entry 20 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 841,449 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.19 to $23.17 inclusive. F9 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of the NMP Trust. Read SEC document |
| April 23, 2020 Filed Apr 25, 2020 01:37 UTC |
Payson NormanDirector
|
SaleCommon Stock | 737 | $21.58 | $15,904.46 |
DisclosureSEC source: 0001209191-20-025740 · doc4.xml · nonDerivative · entry 19 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 844,763 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.18 to $22.16 inclusive. F9 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of the NMP Trust. Read SEC document |
| April 23, 2020 Filed Apr 25, 2020 01:37 UTC |
Payson NormanDirector
|
SaleCommon Stock | 628 | $23.37 | $14,676.36 |
DisclosureSEC source: 0001209191-20-025740 · doc4.xml · nonDerivative · entry 18 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 762,699 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.19 to $23.49 inclusive. F8 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Robert L. Carson, Trustee of the NCP GRAT. The Reporting Person is a trustee of the NCP GRAT. Read SEC document |
| April 23, 2020 Filed Apr 25, 2020 01:37 UTC |
Payson NormanDirector
|
SaleCommon Stock | 4,599 | $22.79 | $104,811.21 |
DisclosureSEC source: 0001209191-20-025740 · doc4.xml · nonDerivative · entry 17 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 763,327 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.19 to $23.17 inclusive. F8 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Robert L. Carson, Trustee of the NCP GRAT. The Reporting Person is a trustee of the NCP GRAT. Read SEC document |
| April 23, 2020 Filed Apr 25, 2020 01:37 UTC |
Payson NormanDirector
|
SaleCommon Stock | 1,023 | $21.58 | $22,076.34 |
DisclosureSEC source: 0001209191-20-025740 · doc4.xml · nonDerivative · entry 16 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 767,926 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.18 to $22.16 inclusive. F8 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Robert L. Carson, Trustee of the NCP GRAT. The Reporting Person is a trustee of the NCP GRAT. Read SEC document |
| April 23, 2020 Filed Apr 25, 2020 01:37 UTC |
Payson NormanDirector
|
SaleCommon Stock | 628 | $23.37 | $14,676.36 |
DisclosureSEC source: 0001209191-20-025740 · doc4.xml · nonDerivative · entry 15 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 762,699 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.19 to $23.49 inclusive. F4 · ownership.nature: The reportable securities are directly held by Melinda B. Payson and Robert L. Carson, Trustee of the MBP GRAT. The Reporting Person's spouse is a trustee of the MBP GRAT. Read SEC document |
| April 23, 2020 Filed Apr 25, 2020 01:37 UTC |
Payson NormanDirector
|
SaleCommon Stock | 4,599 | $22.79 | $104,811.21 |
DisclosureSEC source: 0001209191-20-025740 · doc4.xml · nonDerivative · entry 14 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 763,327 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.19 to $23.17 inclusive. F4 · ownership.nature: The reportable securities are directly held by Melinda B. Payson and Robert L. Carson, Trustee of the MBP GRAT. The Reporting Person's spouse is a trustee of the MBP GRAT. Read SEC document |
| April 23, 2020 Filed Apr 25, 2020 01:37 UTC |
Payson NormanDirector
|
SaleCommon Stock | 1,023 | $21.58 | $22,076.34 |
DisclosureSEC source: 0001209191-20-025740 · doc4.xml · nonDerivative · entry 13 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 767,926 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.18 to $22.16 inclusive. F4 · ownership.nature: The reportable securities are directly held by Melinda B. Payson and Robert L. Carson, Trustee of the MBP GRAT. The Reporting Person's spouse is a trustee of the MBP GRAT. Read SEC document |
| April 22, 2020 Filed Apr 25, 2020 01:37 UTC |
Payson NormanDirector
|
SaleCommon Stock | 1,049 | $23.53 | $24,682.97 |
DisclosureSEC source: 0001209191-20-025740 · doc4.xml · nonDerivative · entry 12 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 845,500 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.34 to $23.83 inclusive. F9 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of the NMP Trust. Read SEC document |
| April 22, 2020 Filed Apr 25, 2020 01:37 UTC |
Payson NormanDirector
|
SaleCommon Stock | 1,559 | $22.98 | $35,825.82 |
DisclosureSEC source: 0001209191-20-025740 · doc4.xml · nonDerivative · entry 11 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 846,549 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.34 to $23.33 inclusive. F9 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of the NMP Trust. Read SEC document |
| April 22, 2020 Filed Apr 25, 2020 01:37 UTC |
Payson NormanDirector
|
SaleCommon Stock | 680 | $21.79 | $14,817.20 |
DisclosureSEC source: 0001209191-20-025740 · doc4.xml · nonDerivative · entry 10 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 848,108 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.31 to $22.22 inclusive. F9 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of the NMP Trust. Read SEC document |
| April 22, 2020 Filed Apr 25, 2020 01:37 UTC |
Payson NormanDirector
|
SaleCommon Stock | 1,212 | $20.83 | $25,245.96 |
DisclosureSEC source: 0001209191-20-025740 · doc4.xml · nonDerivative · entry 9 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 848,788 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.31 to $21.29 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5), (6), (7), (10), (11) and (12) to this Form 4. F3 · balance_after: On December 12, 2019, with the consent of the Issuer, The Norman C. Payson 2018 Grantor Retained Annuity Trust dated November 28, 2018 ("NCP GRAT") transferred 425,000 shares to the The Norman C. and Melinda B. Payson Revocable Trust ("NMP Trust"). On December 13, 2019, with the consent of the Issuer, The Melinda B. Payson 2018 Grantor Retained Annuity Trust dated November 28, 2018 ("MBP GRAT") transferred 425,000 shares to the NMP Trust. F9 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of the NMP Trust. Read SEC document |
| April 22, 2020 Filed Apr 25, 2020 01:37 UTC |
Payson NormanDirector
|
SaleCommon Stock | 1,483 | $23.53 | $34,894.99 |
DisclosureSEC source: 0001209191-20-025740 · doc4.xml · nonDerivative · entry 8 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 768,949 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.34 to $23.83 inclusive. F8 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Robert L. Carson, Trustee of the NCP GRAT. The Reporting Person is a trustee of the NCP GRAT. Read SEC document |
| April 22, 2020 Filed Apr 25, 2020 01:37 UTC |
Payson NormanDirector
|
SaleCommon Stock | 2,113 | $22.99 | $48,577.87 |
DisclosureSEC source: 0001209191-20-025740 · doc4.xml · nonDerivative · entry 7 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 770,432 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.34 to $23.33 inclusive. F8 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Robert L. Carson, Trustee of the NCP GRAT. The Reporting Person is a trustee of the NCP GRAT. Read SEC document |
| April 22, 2020 Filed Apr 25, 2020 01:37 UTC |
Payson NormanDirector
|
SaleCommon Stock | 960 | $21.79 | $20,918.40 |
DisclosureSEC source: 0001209191-20-025740 · doc4.xml · nonDerivative · entry 6 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 772,545 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.31 to $22.22 inclusive. F8 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Robert L. Carson, Trustee of the NCP GRAT. The Reporting Person is a trustee of the NCP GRAT. Read SEC document |
| April 22, 2020 Filed Apr 25, 2020 01:37 UTC |
Payson NormanDirector
|
SaleCommon Stock | 1,694 | $20.83 | $35,286.02 |
DisclosureSEC source: 0001209191-20-025740 · doc4.xml · nonDerivative · entry 5 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 773,505 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.31 to $21.29 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5), (6), (7), (10), (11) and (12) to this Form 4. F3 · balance_after: On December 12, 2019, with the consent of the Issuer, The Norman C. Payson 2018 Grantor Retained Annuity Trust dated November 28, 2018 ("NCP GRAT") transferred 425,000 shares to the The Norman C. and Melinda B. Payson Revocable Trust ("NMP Trust"). On December 13, 2019, with the consent of the Issuer, The Melinda B. Payson 2018 Grantor Retained Annuity Trust dated November 28, 2018 ("MBP GRAT") transferred 425,000 shares to the NMP Trust. F8 · ownership.nature: The reportable securities are directly held by Norman C. Payson and Robert L. Carson, Trustee of the NCP GRAT. The Reporting Person is a trustee of the NCP GRAT. Read SEC document |
| April 22, 2020 Filed Apr 25, 2020 01:37 UTC |
Payson NormanDirector
|
SaleCommon Stock | 1,483 | $23.53 | $34,894.99 |
DisclosureSEC source: 0001209191-20-025740 · doc4.xml · nonDerivative · entry 4 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 768,949 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.34 to $23.83 inclusive. F4 · ownership.nature: The reportable securities are directly held by Melinda B. Payson and Robert L. Carson, Trustee of the MBP GRAT. The Reporting Person's spouse is a trustee of the MBP GRAT. Read SEC document |
| April 22, 2020 Filed Apr 25, 2020 01:37 UTC |
Payson NormanDirector
|
SaleCommon Stock | 2,113 | $22.99 | $48,577.87 |
DisclosureSEC source: 0001209191-20-025740 · doc4.xml · nonDerivative · entry 3 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 770,432 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.34 to $23.33 inclusive. F4 · ownership.nature: The reportable securities are directly held by Melinda B. Payson and Robert L. Carson, Trustee of the MBP GRAT. The Reporting Person's spouse is a trustee of the MBP GRAT. Read SEC document |
| April 22, 2020 Filed Apr 25, 2020 01:37 UTC |
Payson NormanDirector
|
SaleCommon Stock | 960 | $21.79 | $20,918.40 |
DisclosureSEC source: 0001209191-20-025740 · doc4.xml · nonDerivative · entry 2 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 772,545 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.31 to $22.22 inclusive. F4 · ownership.nature: The reportable securities are directly held by Melinda B. Payson and Robert L. Carson, Trustee of the MBP GRAT. The Reporting Person's spouse is a trustee of the MBP GRAT. Read SEC document |
| April 22, 2020 Filed Apr 25, 2020 01:37 UTC |
Payson NormanDirector
|
SaleCommon Stock | 1,694 | $20.83 | $35,286.02 |
DisclosureSEC source: 0001209191-20-025740 · doc4.xml · nonDerivative · entry 1 Payson Norman · CIK 0000898544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 773,505 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 11, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.31 to $21.29 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5), (6), (7), (10), (11) and (12) to this Form 4. F3 · balance_after: On December 12, 2019, with the consent of the Issuer, The Norman C. Payson 2018 Grantor Retained Annuity Trust dated November 28, 2018 ("NCP GRAT") transferred 425,000 shares to the The Norman C. and Melinda B. Payson Revocable Trust ("NMP Trust"). On December 13, 2019, with the consent of the Issuer, The Melinda B. Payson 2018 Grantor Retained Annuity Trust dated November 28, 2018 ("MBP GRAT") transferred 425,000 shares to the NMP Trust. F4 · ownership.nature: The reportable securities are directly held by Melinda B. Payson and Robert L. Carson, Trustee of the MBP GRAT. The Reporting Person's spouse is a trustee of the MBP GRAT. Read SEC document |
| March 09, 2020 Filed Mar 11, 2020 21:51 UTC |
Bealer JenniferEVP, General Counsel
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 9,000 | $0.00 Strike: $23.16 | $0.00 |
DisclosureSEC source: 0001209191-20-018322 · doc4.xml · derivative · entry 2 Bealer Jennifer · CIK 0001789513 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires 2030-03-08 F2 · derivative.exercise_date: Represents an annual merit grant made pursuant to the Issuer's 2019 Equity Incentive Plan. One-fourth (1/4th) of the shares subject to the Option vest on March 9, 2021, and the remaining shares subject to the Option vest in equal quarterly installments thereafter through March 9, 2024, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| March 09, 2020 Filed Mar 11, 2020 21:51 UTC |
Bealer JenniferEVP, General Counsel
|
GrantCommon Stock | 3,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-018322 · doc4.xml · nonDerivative · entry 1 Bealer Jennifer · CIK 0001789513 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,739 F1 · shares: Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). This was an annual merit grant made pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. One-fourth (1/4th) of the RSUs vest on March 9, 2021, and the remaining RSUs vest in equal quarterly installments thereafter through March 9, 2024, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| March 09, 2020 Filed Mar 12, 2020 01:51 UTC |
Greenbaum LisaEVP and Chief Client Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 9,000 | $0.00 Strike: $23.16 | $0.00 |
DisclosureSEC source: 0001209191-20-018323 · doc4.xml · derivative · entry 2 Greenbaum Lisa · CIK 0001791866 · EVP and Chief Client Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires 2030-03-08 F2 · derivative.exercise_date: Represents an annual merit grant made pursuant to the Issuer's 2019 Equity Incentive Plan. One-fourth (1/4th) of the shares subject to the Option vest on March 9, 2021, and the remaining shares subject to the Option vest in equal quarterly installments thereafter through March 9, 2024, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| March 09, 2020 Filed Mar 12, 2020 01:51 UTC |
Greenbaum LisaEVP and Chief Client Officer
|
GrantCommon Stock | 3,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-018323 · doc4.xml · nonDerivative · entry 1 Greenbaum Lisa · CIK 0001791866 · EVP and Chief Client Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500 F1 · shares: Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). This was an annual merit grant made pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. One-fourth (1/4th) of the RSUs vest on March 9, 2021, and the remaining RSUs vest in equal quarterly installments thereafter through March 9, 2024, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 21:38 UTC |
Ajmani KarinEVP, Chief of Strategic Dev.
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 43,047 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001209191-20-011559 · doc4.xml · derivative · entry 4 Ajmani Karin · CIK 0001789516 · EVP, Chief of Strategic Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 344,377 Underlying: Common Stock · 43,047 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on April 1, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 21:38 UTC |
Ajmani KarinEVP, Chief of Strategic Dev.
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 447,472 | $0.00 Strike: $0.87 | $0.00 |
DisclosureSEC source: 0001209191-20-011559 · doc4.xml · derivative · entry 3 Ajmani Karin · CIK 0001789516 · EVP, Chief of Strategic Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,914 Underlying: Common Stock · 447,472 shares Expires 2025-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully Vested. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 21:38 UTC |
Ajmani KarinEVP, Chief of Strategic Dev.
|
Exercise / conversionCommon Stock | 43,047 | $0.91 | $39,172.77 |
DisclosureSEC source: 0001209191-20-011559 · doc4.xml · nonDerivative · entry 2 Ajmani Karin · CIK 0001789516 · EVP, Chief of Strategic Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,128,560 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: This amount eliminates two shares which, as a result of a mathematical error, were first inadvertently included in the amount of securities beneficially owned beginning with the Reporting Person's Form 4 filed October 24, 2019. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 21:38 UTC |
Ajmani KarinEVP, Chief of Strategic Dev.
|
Exercise / conversionCommon Stock | 447,472 | $0.87 | $389,300.64 |
DisclosureSEC source: 0001209191-20-011559 · doc4.xml · nonDerivative · entry 1 Ajmani Karin · CIK 0001789516 · EVP, Chief of Strategic Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,085,513 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: This amount eliminates two shares which, as a result of a mathematical error, were first inadvertently included in the amount of securities beneficially owned beginning with the Reporting Person's Form 4 filed October 24, 2019. Read SEC document |
| January 22, 2020 Filed Jan 26, 2021 22:24 UTC |
KPCB XIII Associates, LLC10% owner
|
OtherCommon Stock | 489,038 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-007732 · tm214251-1_4seq1.xml · nonDerivative · entry 3 KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 90,310 F5 · kind: Represents a pro-rata in-kind distribution of Common Stock of the Issuer by XIII Associates without consideration to its members. F6 · ownership.nature: Consists of 90,310 shares of Common Stock of the Issuer held by XIII Associates. Read SEC document |
| January 22, 2020 Filed Jan 26, 2021 22:24 UTC |
KPCB XIII Associates, LLC10% owner
|
OtherCommon Stock | 522,904 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-007732 · tm214251-1_4seq1.xml · nonDerivative · entry 2 KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 579,348 F3 · kind: Represents a change in the form of ownership as a result of the receipt by XIII Associates of shares in the Fund Distribution. F4 · ownership.nature: Consists of 579,348 shares of Common Stock of the Issuer held by XIII Associates. Read SEC document |
| January 22, 2020 Filed Jan 26, 2021 22:24 UTC |
KPCB XIII Associates, LLC10% owner
|
OtherCommon Stock | 1,398,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-007732 · tm214251-1_4seq1.xml · nonDerivative · entry 1 KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,295,896 F1 · kind: Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Kleiner Perkins Caufield & Byers XIII, LLC ("KPCB XIII") without consideration to its members (the "Fund Distribution"). Excludes 101,100 shares of Common Stock for which a change in the form of beneficial ownership for individuals and entities associated with Kleiner Perkins Caufield & Byers occurred. F2 · ownership.direct: The shares are directly held by KPCB XIII. All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee." The managing member of KPCB XIII is KPCB XIII Associates, LLC ("XIII Associates"). The voting and dispositive control over the shares is shared by individual managing directors of XIII Associates, none of whom has veto power. Excludes 599,553 shares of Common Stock beneficially owned by individuals and entities associated with Kleiner Perkins Caufield & Byers and held for convenience in the name of "KPCB Holdings, Inc. as nominee," for the accounts of such individuals and entities who each exercise their own voting and dispositive control over such shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.